Global Nuclear Medicine Diagnostics Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report ID: ARS1436 | Category: Healthcare | Pages: 122 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4680.00 Multi User-$7900.00

Report Description
View Table of Contents

Report Summary

The global Nuclear Medicine Diagnostics market size in 2022 is XX million US dollars, and it is expected to be 13210.0 million US dollars by 2029, with a compound annual growth rate of 10.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Nuclear Medicine Diagnostics market include Cardinal Health (U.S.), General Electric (U.S.), Lantheus (U.S.), Bayer AG (Germany), and Bracco Diagnostic Inc. (Italy). The share of the top 3 players in the Nuclear Medicine Diagnostics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Nuclear Medicine Diagnostics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. SPECT Radiopharmaceuticals accounted for XX% of Nuclear Medicine Diagnostics market in 2022. PET Radiopharmaceuticals share of XX%.
Hospitals and diagnostic centers accounted for XX% of the Nuclear Medicine Diagnostics market in 2022. Research Institutes accounts for XX%.

The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Nuclear Medicine Diagnostics markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.

Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.

Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.

The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
Europe
China
Japan
Korea
Southeast Asia
India
South America
Middle East & Africa

Player list
Cardinal Health (U.S.)
General Electric (U.S.)
Lantheus (U.S.)
Bayer AG (Germany)
Bracco Diagnostic Inc. (Italy)
NorthStar Medical Radioisotopes, LLC (U.S.)
Eckert & Ziegler. (Germany)
Jubilant DraxImage, Inc. (Canada)
PharmaLogic Holdings Corp. (U.S.)
Institute of Isotopes Co., Ltd (Hungary)
SHINE Medical Technologies, LLC (U.S.)
Global Medical Solutions LLC (China)

Types list
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals

Application list
Hospitals and diagnostic centers
Research Institutes

Table of Content

1 Nuclear Medicine Diagnostics Market Introduction and Overview
1.1 Nuclear Medicine Diagnostics Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Nuclear Medicine Diagnostics Revenue and Market Share by Manufacturer
2.2 Manufacturers Nuclear Medicine Diagnostics Production Sites, Area Served, Product Types
2.3 Nuclear Medicine Diagnostics Market Competitive Situation and Trends
2.3.1 Nuclear Medicine Diagnostics Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Cardinal Health (U.S.)
3.1.1 Cardinal Health (U.S.) Company Profile
3.1.2 Nuclear Medicine Diagnostics Product Overview
3.1.3 Cardinal Health (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.1.4 Cardinal Health (U.S.) Business Overview
3.2 General Electric (U.S.)
3.2.1 General Electric (U.S.) Company Profile
3.2.2 Nuclear Medicine Diagnostics Product Overview
3.2.3 General Electric (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.2.4 General Electric (U.S.) Business Overview
3.3 Lantheus (U.S.)
3.3.1 Lantheus (U.S.) Company Profile
3.3.2 Nuclear Medicine Diagnostics Product Overview
3.3.3 Lantheus (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.3.4 Lantheus (U.S.) Business Overview
3.4 Bayer AG (Germany)
3.4.1 Bayer AG (Germany) Company Profile
3.4.2 Nuclear Medicine Diagnostics Product Overview
3.4.3 Bayer AG (Germany) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.4.4 Bayer AG (Germany) Business Overview
3.5 Bracco Diagnostic Inc. (Italy)
3.5.1 Bracco Diagnostic Inc. (Italy) Company Profile
3.5.2 Nuclear Medicine Diagnostics Product Overview
3.5.3 Bracco Diagnostic Inc. (Italy) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.5.4 Bracco Diagnostic Inc. (Italy) Business Overview
3.6 NorthStar Medical Radioisotopes, LLC (U.S.)
3.6.1 NorthStar Medical Radioisotopes, LLC (U.S.) Company Profile
3.6.2 Nuclear Medicine Diagnostics Product Overview
3.6.3 NorthStar Medical Radioisotopes, LLC (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.6.4 NorthStar Medical Radioisotopes, LLC (U.S.) Business Overview
3.7 Eckert & Ziegler. (Germany)
3.7.1 Eckert & Ziegler. (Germany) Company Profile
3.7.2 Nuclear Medicine Diagnostics Product Overview
3.7.3 Eckert & Ziegler. (Germany) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.7.4 Eckert & Ziegler. (Germany) Business Overview
3.8 Jubilant DraxImage, Inc. (Canada)
3.8.1 Jubilant DraxImage, Inc. (Canada) Company Profile
3.8.2 Nuclear Medicine Diagnostics Product Overview
3.8.3 Jubilant DraxImage, Inc. (Canada) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.8.4 Jubilant DraxImage, Inc. (Canada) Business Overview
3.9 PharmaLogic Holdings Corp. (U.S.)
3.9.1 PharmaLogic Holdings Corp. (U.S.) Company Profile
3.9.2 Nuclear Medicine Diagnostics Product Overview
3.9.3 PharmaLogic Holdings Corp. (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.9.4 PharmaLogic Holdings Corp. (U.S.) Business Overview
3.10 Institute of Isotopes Co., Ltd (Hungary)
3.10.1 Institute of Isotopes Co., Ltd (Hungary) Company Profile
3.10.2 Nuclear Medicine Diagnostics Product Overview
3.10.3 Institute of Isotopes Co., Ltd (Hungary) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.10.4 Institute of Isotopes Co., Ltd (Hungary) Business Overview
3.11 SHINE Medical Technologies, LLC (U.S.)
3.11.1 SHINE Medical Technologies, LLC (U.S.) Company Profile
3.11.2 Nuclear Medicine Diagnostics Product Overview
3.11.3 SHINE Medical Technologies, LLC (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.11.4 SHINE Medical Technologies, LLC (U.S.) Business Overview
3.12 Global Medical Solutions LLC (China)
3.12.1 Global Medical Solutions LLC (China) Company Profile
3.12.2 Nuclear Medicine Diagnostics Product Overview
3.12.3 Global Medical Solutions LLC (China) Nuclear Medicine Diagnostics Market Performance (2018-2023)
3.12.4 Global Medical Solutions LLC (China) Business Overview
4 Global Nuclear Medicine Diagnostics Historical and Forecast Market Analysis by Type
4.1 Global Nuclear Medicine Diagnostics Revenue and Market Share by Type
4.2 Global Nuclear Medicine Diagnostics Revenue Market Forecast by Type (2023-2029)
5 Global Nuclear Medicine Diagnostics Historical and Forecast Market Analysis by Application
5.1 Global Nuclear Medicine Diagnostics Revenue Market Share by Application (2018-2023)
5.2 Nuclear Medicine Diagnostics Revenue Market Forecast by Application (2023-2029)
6 Global Market Growth Trends Analysis
6.1 Global Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2 Nuclear Medicine Diagnostics Growth Trends Analysis by Regions
6.2.1 Nuclear Medicine Diagnostics Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Nuclear Medicine Diagnostics Historic Revenue Market Size by Regions (2018-2023)
6.2.3 Nuclear Medicine Diagnostics Forecasted Revenue Market Size by Regions (2023-2029)
6.2.4 North America Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.5 Europe Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.6 China Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.7 Japan Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.8 Korea Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.9 Southeast Asia Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.10 India Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.11 South America Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
6.2.12 Middle East & Africa Nuclear Medicine Diagnostics Market Size & Forecast (2018-2029)
7 North America
7.1 North America Nuclear Medicine Diagnostics Revenue by Players
7.2 North America Nuclear Medicine Diagnostics Revenue by Types
7.3 North America Nuclear Medicine Diagnostics Revenue by Applications
7.4 North America Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Nuclear Medicine Diagnostics Revenue by Players
8.2 Europe Nuclear Medicine Diagnostics Revenue by Types
8.3 Europe Nuclear Medicine Diagnostics Revenue by Applications
8.4 Europe Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
8.5 Europe PEST Analysis
9 China
9.1 China Nuclear Medicine Diagnostics Revenue by Players
9.2 China Nuclear Medicine Diagnostics Revenue by Types
9.3 China Nuclear Medicine Diagnostics Revenue by Applications
9.4 China Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
9.5 China PEST Analysis
10 Japan
10.1 Japan Nuclear Medicine Diagnostics Revenue by Players
10.2 Japan Nuclear Medicine Diagnostics Revenue by Types
10.3 Japan Nuclear Medicine Diagnostics Revenue by Applications
10.4 Japan Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Nuclear Medicine Diagnostics Revenue by Players
11.2 Korea Nuclear Medicine Diagnostics Revenue by Types
11.3 Korea Nuclear Medicine Diagnostics Revenue by Applications
11.4 Korea Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Nuclear Medicine Diagnostics Revenue by Players
12.2 Southeast Asia Nuclear Medicine Diagnostics Revenue by Types
12.3 Southeast Asia Nuclear Medicine Diagnostics Revenue by Applications
12.4 Southeast Asia Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Nuclear Medicine Diagnostics Revenue by Players
13.2 India Nuclear Medicine Diagnostics Revenue by Types
13.3 India Nuclear Medicine Diagnostics Revenue by Applications
13.4 India Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
13.5 India PEST Analysis
14 South America
14.1 South America Nuclear Medicine Diagnostics Revenue by Players
14.2 South America Nuclear Medicine Diagnostics Revenue by Types
14.3 South America Nuclear Medicine Diagnostics Revenue by Applications
14.4 South America Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Nuclear Medicine Diagnostics Revenue by Players
15.2 Middle East & Africa Nuclear Medicine Diagnostics Revenue by Types
15.3 Middle East & Africa Nuclear Medicine Diagnostics Revenue by Applications
15.4 Middle East & Africa Nuclear Medicine Diagnostics Revenue, Gross and Gross Margin (2018-2023)
15.5 Middle East & Africa PEST Analysis
16 Nuclear Medicine Diagnostics Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Nuclear Medicine Diagnostics Industrial Chain Analysis
17 Nuclear Medicine Diagnostics Industry Dynamic Analysis
17.1 Nuclear Medicine Diagnostics Market Trends Analysis
17.2 Nuclear Medicine Diagnostics Market Drivers Analysis
17.3 Nuclear Medicine Diagnostics Market Challenges Analysis
17.4 Nuclear Medicine Diagnostics Market Restraints Analysis
18 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Nuclear Medicine Diagnostics Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?